FIELD: organic chemistry, medicine. SUBSTANCE: invention describes the novel compounds of the general formula (Ia) and (Ib) where R1 means C1-C6-alkyl; R2 is hydrogen atom, SiEt3 or radical of the formula C(=O)-(CH2)yNR21R22 where j means the whole number 1-3; R21 and R22 mean C1-C3-alkyl; R3 is hydrogen atom or SiEt3; R4 is hydrogen atom or SiEt3, or their proline analogs, or their pharmaceutically acceptable salts. Proposed compounds are useful for induction of immunosuppression and treatment of transplant rejection, homologous disease, autoimmune and inflammatory sicknesses, solid tumors, fungal infections, leukosis, lymphomas, differentiated T-cells and hyperproliferative vascular disorders. Invention describes also method of induction of immunosuppression, treatment or prophylaxis of transplant rejection or homologous disease, method of treatment or prophylaxis of hyperproliferative vascular disorders. EFFECT: new compounds indicated above, valuable medicinal properties. 22 cl, 1 tbl, 7 ex
Title |
Year |
Author |
Number |
RAPAMYCIN HYDROXYESTERS, METHOD OF THEIR SYNTHESIS AND METHODS OF TREATMENT |
1995 |
- Dzheral'D Stenli Skotnitski
- Kristina Luiza Leon
- Gaj Alan Shizer
|
RU2134267C1 |
RAPAMYCIN 42-OXIMES AND HYDROXYLAMINES, METHOD OF SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENT |
1995 |
- Amedeo Arturo Failli
- Gaj Alan Shikhser
- Oleg Igorevich Blejman
|
RU2172316C2 |
DERIVATIVES OF SPIRO-[ISOQUINOLINE-4-(1H)-3-PYRROLIDINE]-1,2',3,5'-(2H)-TETR- -ONE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION USED FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS-RELATED COMPLICATIONS |
1991 |
- Majkl Sotirios Malamas[Gr]
|
RU2110518C1 |
RAPAMYCIN DERIVATIVES, A PHARMACEUTICAL COMPOSITION AND A METHOD OF IMMUNODEPRESSION STIMULATING |
1993 |
- Venling Kao
- Magid A.Abou-Gkharbia
- Robert L.Vogel
|
RU2126409C1 |
SUBSTITUTED PYRIMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR N-OXIDES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1992 |
- Dzhon Vatson Ehllingboj
- Madelen Nikajdo
- Zhak Framros Bazhli
|
RU2113437C1 |
TRICYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD |
1998 |
- Duzha Dzhon Pol
- Chehn Piter Sinchun
- Olbrajt Dzhej Donal'D
- Behgli Dzhekhehn Frehmroz
- Fehjlli Amedeo Arturo
- Ehshvell Mark Ehntoni
- Molinari Al'Bert Dzhon
- Kadzhjano Tomas Dzhozef
- Tribul'Ski Judzhin Dzhon
|
RU2213094C2 |
RAPAMYCIN ESTERS |
1996 |
|
RU2160739C2 |
DERIVATIVES OF [([2- (AMINO -3,4-DIOXO -1-CYCLOBUTENE -1-YL)AMINO]ALKYL)] ACIDS |
1992 |
- Uil'Jam Alvin Kinni[Us]
- Dinna Kolett Garrison[Us]
|
RU2039035C1 |
DERIVATIVES OF THIAZOLIDINEDIONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF TREATMENT OF MAMMALIAN WITH HYPERGLYCAEMIA, A PHARMACEUTICAL COMPOSITION |
1995 |
- Dzhej Ehdvard Robel'
- Zenan Li
- Ehrlin Dzhoan Ditrikh
|
RU2126395C1 |
AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-E]-INDOLE-8-ONE COMPOUNDS AND METHOD OF TREATMENT |
1996 |
- Stehk Gehri Pol
- M'Jusho Richard Ehrik
- Bravo Bajron Abel'
- Kang Jang Khi
|
RU2178416C2 |